ENLIVEN THERAPEUTICS, INC. (ELVN)

SEC filing

ENLIVEN THERAPEUTICS, INC.

ELVN · CIK 1672619

4 · Aug 19, 2026 · CHIEF FINANCIAL OFFICER Hohl Benjamin sold 6,018 shares at $58.58/share ($352.6K)

CHIEF FINANCIAL OFFICER Hohl Benjamin sold 6,018 shares at $58.58/share ($352.6K)

xslF345X06/form4-08192026_080843.xml

xslF345X06/form4-08192026_080843.xmlSEC.gov

Graphics and non-inline formats (not embedded below).